Takayuki Kamiya, Santen Pharmaceutical Co., Ltd. (F);
Tsuneaki Omae, Alcon (R), Bayer Yakuhin, Ltd. (R), Kowa (R), Novartis pharma (F), Santen Pharmaceutical Co., Ltd. (R), Topcon (F);
Seigo Nakabayashi, None;
Takafumi Yoshioka, None;
Shinji Ono, Alcon (R), HOYA (R), Novartis pharma (F), Otsuka Pharmaceutical Co., Ltd (R);
Kengo Takahashi, None;
Akira Tanner, None;
Yasuo Yanagi, None;
Akitoshi Yoshida, Alcon (F), AMO (F), HOYA (F), MSD (F), Nidek (P), Novartis pharma (F), Otsuka Pharmaceutical Co., Ltd (F), Pfizer Inc (F), Santen Pharmaceutical Co., Ltd. (F), Senju Pharmaceutical Co., Ltd. (F), Tomey corporation (P), Topcon (P), Topcon (F)